India's Supreme Court has directed state health secretaries to meet with the health ministry to strengthen clinical-trial regulations at a time of deepening concern over a slowdown in approvals for such trials. The Indian Society for Clinical Research said that delays have "the greatest impact on patients for many of whom clinical trial provides early access to a new treatment and for others, the last option or hope of a cure."

Related Summaries